131 related articles for article (PubMed ID: 31359401)
21. Profiling of the transcriptional response to all-trans retinoic acid in breast cancer cells reveals RARE-independent mechanisms of gene expression.
Coyle KM; Maxwell S; Thomas ML; Marcato P
Sci Rep; 2017 Nov; 7(1):16684. PubMed ID: 29192143
[TBL] [Abstract][Full Text] [Related]
22. A novel RARbeta isoform directed by a distinct promoter P3 and mediated by retinoic acid in breast cancer cells.
Peng X; Maruo T; Cao Y; Punj V; Mehta R; Das Gupta TK; Christov K
Cancer Res; 2004 Dec; 64(24):8911-8. PubMed ID: 15604252
[TBL] [Abstract][Full Text] [Related]
23. Nucleostemin silencing induces differentiation and potentiates all-trans-retinoic acid effects in human acute promyelocytic leukemia NB4 cells via autophagy.
Fakhimahmadi A; Nazmi F; Rahmati M; Bonab NM; Hashemi M; Moosavi MA
Leuk Res; 2017 Dec; 63():15-21. PubMed ID: 29096331
[TBL] [Abstract][Full Text] [Related]
24. Enhancement of caffeic acid phenethyl ester on all-trans retinoic acid-induced differentiation in human leukemia HL-60 cells.
Kuo HC; Kuo WH; Lee YJ; Wang CJ; Tseng TH
Toxicol Appl Pharmacol; 2006 Oct; 216(1):80-8. PubMed ID: 16766008
[TBL] [Abstract][Full Text] [Related]
25. Insulin-like growth factor binding protein-3 prevents retinoid receptor heterodimerization: implications for retinoic acid-sensitivity in human breast cancer cells.
Schedlich LJ; O'Han MK; Leong GM; Baxter RC
Biochem Biophys Res Commun; 2004 Jan; 314(1):83-8. PubMed ID: 14715249
[TBL] [Abstract][Full Text] [Related]
26. A novel all-trans retinoid acid derivatives inhibits the migration of breast cancer cell lines MDA-MB-231 via myosin light chain kinase involving p38-MAPK pathway.
Wang B; Yan Y; Zhou J; Zhou Q; Gui S; Wang Y
Biomed Pharmacother; 2013 Jun; 67(5):357-62. PubMed ID: 23602051
[TBL] [Abstract][Full Text] [Related]
27. A novel all-trans retinoid acid derivative induces apoptosis in MDA-MB-231 breast cancer cells.
Wang B; Yan YW; Zhou Q; Gui SY; Chen FH; Wang Y
Asian Pac J Cancer Prev; 2014; 15(24):10819-24. PubMed ID: 25605183
[TBL] [Abstract][Full Text] [Related]
28. Induction of retinoid resistance in breast cancer cells by overexpression of cJun.
Yang L; Kim HT; Munoz-Medellin D; Reddy P; Brown PH
Cancer Res; 1997 Oct; 57(20):4652-61. PubMed ID: 9377582
[TBL] [Abstract][Full Text] [Related]
29. Cross-talk between retinoic acid and interferons: molecular mechanisms of interaction in acute promyelocytic leukemia cells.
Garattini E; Mologni L; Ponzanelli I; Terao M
Leuk Lymphoma; 1998 Aug; 30(5-6):467-75. PubMed ID: 9711909
[TBL] [Abstract][Full Text] [Related]
30. Am80 induces neuronal differentiation in a human neuroblastoma NH-12 cell line.
Shiohira H; Kitaoka A; Shirasawa H; Enjoji M; Nakashima M
Int J Mol Med; 2010 Sep; 26(3):393-9. PubMed ID: 20664956
[TBL] [Abstract][Full Text] [Related]
31. Retinoic acid receptor alpha and retinoid-X receptor-specific agonists synergistically target telomerase expression and induce tumor cell death.
Pendino F; Dudognon C; Delhommeau F; Sahraoui T; Flexor M; Bennaceur-Griscelli A; Lanotte M; Ségal-Bendirdjian E
Oncogene; 2003 Dec; 22(57):9142-50. PubMed ID: 14668795
[TBL] [Abstract][Full Text] [Related]
32. [All-trans retinoic acid (ATRA) in prevention and cancer therapy].
Hoffman E; Mielicki WP
Postepy Hig Med Dosw (Online); 2010 Jun; 64():284-90. PubMed ID: 20558866
[TBL] [Abstract][Full Text] [Related]
33. Antitumor activity of the retinoid-related molecules (E)-3-(4'-hydroxy-3'-adamantylbiphenyl-4-yl)acrylic acid (ST1926) and 6-[3-(1-adamantyl)-4-hydroxyphenyl]-2-naphthalene carboxylic acid (CD437) in F9 teratocarcinoma: Role of retinoic acid receptor gamma and retinoid-independent pathways.
Parrella E; Giannì M; Fratelli M; Barzago MM; Raska I; Diomede L; Kurosaki M; Pisano C; Carminati P; Merlini L; Dallavalle S; Tavecchio M; Rochette-Egly C; Terao M; Garattini E
Mol Pharmacol; 2006 Sep; 70(3):909-24. PubMed ID: 16788091
[TBL] [Abstract][Full Text] [Related]
34. Role of mitochondria and cardiolipins in growth inhibition of breast cancer cells by retinoic acid.
Terao M; Goracci L; Celestini V; Kurosaki M; Bolis M; Di Veroli A; Vallerga A; Fratelli M; Lupi M; Corbelli A; Fiordaliso F; Gianni M; Paroni G; Zanetti A; Cruciani G; Garattini E
J Exp Clin Cancer Res; 2019 Oct; 38(1):436. PubMed ID: 31665044
[TBL] [Abstract][Full Text] [Related]
35. all-trans-Retinoic acid-induced expression and regulation of retinoic acid 4-hydroxylase (CYP26) in human promyelocytic leukemia.
Ozpolat B; Mehta K; Tari AM; Lopez-Berestein G
Am J Hematol; 2002 May; 70(1):39-47. PubMed ID: 11994980
[TBL] [Abstract][Full Text] [Related]
36. [Basic and clinical studies of the gene product-targeting therapy based on leukemogenesis--editorial].
Chen SJ; Chen LJ; Zhou GB
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Feb; 13(1):1-8. PubMed ID: 15748426
[TBL] [Abstract][Full Text] [Related]
37. Relationship between retinoic acid receptor alpha gene expression and growth-inhibitory effect of all-trans retinoic acid on canine tumor cells.
Miyajima N; Watanabe M; Ohashi E; Mochizuki M; Nishimura R; Ogawa H; Sugano S; Sasaki N
J Vet Intern Med; 2006; 20(2):348-54. PubMed ID: 16594593
[TBL] [Abstract][Full Text] [Related]
38. A retinoid X receptor (RXR)-selective retinoid reveals that RXR-alpha is potentially a therapeutic target in breast cancer cell lines, and that it potentiates antiproliferative and apoptotic responses to peroxisome proliferator-activated receptor ligands.
Crowe DL; Chandraratna RA
Breast Cancer Res; 2004; 6(5):R546-55. PubMed ID: 15318936
[TBL] [Abstract][Full Text] [Related]
39. RACK1 deficiency synergizes with all-trans retinoic acid to induce apoptosis in human acute promyelocytic leukemia cells.
Wu H; Liu J; Huang X; Pian L; Cheng Q; Wang Q; Zhao M; Lin Z; Shen B; Zhang J; Li S; Wang J
Mol Cell Biochem; 2019 Jan; 451(1-2):155-163. PubMed ID: 30019299
[TBL] [Abstract][Full Text] [Related]
40. All-trans, 13-cis and 9-cis retinoic acids induce a fully reversible growth inhibition in HNSCC cell lines: implications for in vivo retinoic acid use.
Giannini F; Maestro R; Vukosavljevic T; Pomponi F; Boiocchi M
Int J Cancer; 1997 Jan; 70(2):194-200. PubMed ID: 9009160
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]